Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

FDA Roundup: December 5, 2023
Tue, 05 Dec 2023 16:59:37 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA, USDA and EPA Propose National Strategy to Reduce U.S. Food Loss and Waste
Mon, 04 Dec 2023 09:04:50 EST

  FDA, USDA and EPA release draft strategy to prevent the loss and waste of food and increase recycling of organics to support a circular economy for all, reduce greenhouse gas emissions, save households and businesses money, and build cleaner communities

FDA Roundup: December 1, 2023
Fri, 01 Dec 2023 16:46:57 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: November 28, 2023
Tue, 28 Nov 2023 16:24:59 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Cautions Public of Safety Issue with Philips’ DreamStation 2 CPAP Machines
Tue, 28 Nov 2023 15:36:57 EST

  The FDA is alerting patients and healthcare providers of an emerging safety issue involving Philips Respironics’ DreamStation 2 Continuous Positive Airway Pressure (CPAP) machines used for treatment of obstructive sleep apnea

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
Mon, 27 Nov 2023 17:32:36 EST

  The FDA approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Nirogacestat is a new molecular entity and the first drug to be approved for the treatment of patients with desmoid tumors, a subtype of soft tissue sarcomas.

FDA Roundup: November 21, 2023
Tue, 21 Nov 2023 15:51:25 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: November 17, 2023
Fri, 17 Nov 2023 16:18:18 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Federal Judge Enters Consent Decrees Against Utah-Based Dietary Supplement Distributor and Manufacturer of Balance of Nature Products
Thu, 16 Nov 2023 10:36:25 EST

  A dietary supplement distributor, dietary supplement manufacturer, and two executives have been ordered by a federal court to stop selling Balance of Nature products

FDA Grants Marketing Authorization of First Test for Chlamydia and Gonorrhea with at-home Sample Collection
Wed, 15 Nov 2023 15:46:28 EST

  Today, the FDA granted marketing authorization of first diagnostic test for chlamydia and gonorrhea with at-home sample collection.

Federal Court Enters Consent Decree Against Arizona-based Company for Distribution of Unapproved Contraceptive Drugs
Wed, 15 Nov 2023 15:23:36 EST

  The U.S. District Court for the District of Arizona entered a consent decree of permanent injunction ordering Smart Women’s Choice, Inc., an Arizona-based company.

FDA Roundup: November 14, 2023
Tue, 14 Nov 2023 15:24:57 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus
Thu, 09 Nov 2023 16:59:30 EST

  The FDA approved Ixchiq, the first vaccine for prevention of disease caused by chikungunya virus in individuals 18 years of age and older who are at increased risk of exposure to chikungunya virus.

FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder
Thu, 09 Nov 2023 14:28:57 EST

  The FDA approved Adzynma, the first genetically engineered protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare and life-threatening blood clotting disorder.

FDA Clears First COVID-19 Home Antigen Test
Thu, 09 Nov 2023 14:06:10 EST

  The FDA cleared for marketing the first over-the-counter (OTC) antigen test for COVID-19. ACON Laboratories’ Flowflex COVID-19 Antigen Home Test, originally authorized for emergency use in 2021, is now the second home COVID-19 test to successfully complete a traditional FDA premarket review pathway.

FDA Approves New Medication for Chronic Weight Management
Wed, 08 Nov 2023 12:11:00 EST

  The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a reduced calorie diet and increased physical activity.

FDA Roundup: November 7, 2023
Tue, 07 Nov 2023 15:38:09 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: November 3, 2023
Fri, 03 Nov 2023 15:05:45 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

National Survey Shows Drop in E-Cigarette Use Among High School Students
Thu, 02 Nov 2023 13:47:48 EDT

  Today, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), released federal data from the 2023 National Youth Tobacco Survey (NYTS) on tobacco product use among U.S. youth.

FDA Proposes to Ban Food Additive, Continues Assessments of Additional Chemicals
Thu, 02 Nov 2023 10:01:46 EDT

  The FDA proposed to revoke the regulation authorizing the use of brominated vegetable oil (BVO) in food. The agency concluded that the use of BVO in food is no longer considered safe after the results of studies conducted in collaboration with the National Institutes of Health (NIH) found the potent

Food and Drugs Administration--Recalls/Safety Alerts

TGD Cuts, LLC Recalls Certain Fresh-Cut Fruit Cup, Clamshell and Tray Products Due to Possible Health Risk
Tue, 05 Dec 2023 17:49:00 EST

  TGD Cuts, LLC has initiated a voluntary recall of the specific fresh-cut fruit cup, clamshell and tray products listed below because they contain cantaloupe from TruFresh which has the potential to be contaminated with Salmonella.

Lara’s Bakery 3 LLC, Issues Allergy Alert on Undeclared (Sesame Seed, Coconut, Soy, Wheat, Milk and Eggs) in Pan de Racho, Panque, Tres Leches, Chocoflan and Pan Surtido
Tue, 05 Dec 2023 16:28:00 EST

  Lara’s Bakery 3 LLC of Marshalltown, IA is recalling Pan de Racho, Panque, and Pan Surtido (Concha, Cema, Polvoron, Flan, Chocoflan, Tres Leches, Tostado de Guatemala, Pan de Guatemala, Canasta, Garibaldi, Marianas, Muffin, Pan Fino, Pastel de Glass, Pan de Trigo, Puerco, Bolillo, Telera), because i

Pacific Trellis Fruit Recalls Malichita Brand Cantaloupes Due to Possible Health Risk
Fri, 01 Dec 2023 20:30:00 EST

  Pacific Trellis Fruit, LLC is initiating a voluntary recall of 4,872 cases of Malichita brand whole cantaloupe. The voluntary recall is due to the FDAs ongoing investigation of an outbreak involving Malichita brand cantaloupe. The cantaloupes have the potential to be contaminated with Salmonella. Sa

Allergy Alert for Undeclared Peanut in Maggi 2 Minute Noodles
Fri, 01 Dec 2023 13:43:00 EST

  New India Bazar, Milpitas, CA is recalling 2,400 packets of Maggi 2 Minute Noodles 280g and 1,200 packets Maggi 2 Minute Noodles 560g, because it may contain undeclared Peanut allergen. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic r

Manischewitz Issues a Product Mislabeling Advisory and Voluntary Recall on Some Very Limited Units of their Dark Chocolate Coins
Fri, 01 Dec 2023 00:00:00 EST

  Manischewitz, is recalling Manischewitz Dark Chocolate Coins because it may contain undeclared milk. People who have an allergy or severe sensitivity to milk, run the risk of serious or life-threatening allergic reaction if they consume these products. The Manischewitz Dark Chocolate Coins were dis

Gaws Gourmet Foods Issues Allergy Alert on Undeclared Sesame in Sandwiches
Thu, 30 Nov 2023 16:09:00 EST

  Gaws Gourmet Foods of Marysville, MI, is recalling three varieties of 8” deli subs, and two varieties of breakfast bagel sandwiches because they may contain undeclared sesame.

Cut Fruit Express Recalls "Fresh Cut Fruit Mix Containing Cantaloupe" Because of Possible Health Risk
Thu, 30 Nov 2023 09:48:00 EST

  Cut Fruit Express Inc. of Inver Grove Heights, MN, is recalling Caribou Coffee Fruit Mix CHPG 6.5oz, and Cut Fruit Express Brand of 6.5oz, 15oz, 16oz, 32oz packages of Fruit Mix contains Cantaloupes and Food service packages of 5lb tray, 10lb bag, 25lb Pail, because it has the potential to be conta

Meta Herbal Issues Voluntary Nationwide Recall of Magnum XXL 9800 Capsules Due to Presence of Undeclared Sildenafil
Wed, 29 Nov 2023 13:58:00 EST

  E. Hampton NY- Meta Herbal is voluntarily recalling 500 blister packs of Magnum XXL 9800 2000 mg per capsule, to the consumer level. The products have been found to be tainted with Sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) found in FDA-approved products f

GHGA, LLC, in Coordination with Sofia Produce, LLC DBA Trufresh, Voluntarily Recalls Select Fresh-Cut Fruit Products Due to Possible Salmonella Contamination
Wed, 29 Nov 2023 00:00:00 EST

  GHGA, LLC is voluntarily recalling select fresh-cut products made from whole cantaloupe subject to a previously announced product recall initiated by Sofia Produce, LLC dba Trufresh, due to potential Salmonella contamination. Salmonella is an organism which can cause serious and sometimes fatal inf

Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume
Wed, 29 Nov 2023 00:00:00 EST

  Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump. The Correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and i

Bix Produce Issues Safety Alert on Cut Cantaloupe Products Due to Potential Salmonella Contamination
Tue, 28 Nov 2023 10:49:00 EST

  Little Canada, MN., Nov. 27, 2023 – Bix Produce of Little Canada, MN., is issuing a voluntary recall of Grab N’ Go containers of cut cantaloupe and mixed fruit cups due to the potential for Salmonella contamination in the products. These cantaloupe products were derived from cantaloupes that are in

Doctors Scientific Organica Announces Voluntary Recall of Limited Quantity of Burn Boot Camp Afterburn Grass-Fed Whey Protein Bars (60 grams) Due to Potential Presence of Foreign Material
Tue, 28 Nov 2023 10:46:00 EST

  Riviera Beach, FL – Doctors Scientific Organica is initiating a voluntary recall of a limited quantity of Burn Boot Camp Afterburn Grass-Fed Whey Protein Bars (60 grams) Triple Chocolate Almond flavor products due to the potential presence of foreign material, including disposable hairnet, shrink wr

Kwik Trip, Inc. Recalls Specific Fruit Cups and Trays Due to Potential Salmonella Contamination
Mon, 27 Nov 2023 00:00:00 EST

  Kwik Trip, Inc. has initiated a voluntary recall of three varieties of fresh-cut fruit cup and tray products listed below because they contain cantaloupe from TruFresh which has the potential to be contaminated with Salmonella. Salmonella is an organism which can cause serious and sometime fatal inf

Urgent Food Recall— Raspberry Crème Filled Cookie
Fri, 24 Nov 2023 18:00:00 EST

  Wine Country Gift Baskets is taking precautionary measures of voluntarily recalling all gift baskets produced with Acorn Baking Company raspberry crème filled cookies. During production, it was discovered that some packages of the raspberry crème filled cookies contained hazelnut crème filled cookie

Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization
Fri, 24 Nov 2023 10:38:00 EST

  Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. The issue was identifi

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Fri, 24 Nov 2023 00:00:00 EST

  Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third- party lab found that samples fr

CF Dallas, LLC, in Coordination with Sofia Produce, LLC Dba Trufresh, Voluntarily Recalls Select Fresh-Cut Fruit Products Due to Possible Salmonella Contamination
Wed, 22 Nov 2023 19:00:00 EST

  CF Dallas, LLC is voluntarily recalling select fresh-cut products made from whole cantaloupe subject to a previously announced product recall initiated by Sofia Produce, LLC dba Trufresh due to potential Salmonella contamination.

Crown Jewels Produce Recalls “Malichita / Z Farms” Label of Whole Cantaloupes Because of Possible Health Risk Due to Salmonella
Wed, 22 Nov 2023 14:30:00 EST

  Jewel Marketing and Agribusiness LLC. (dba Crown Jewels Produce) of Fresno, CA is recalling all sizes of 1960 boxes of Malichita / Z Farms Cantaloupes sold between October 31, 2023 and November 9, 2023, because it has the potential to be contaminated with Salmonella, an organism which can cause seri

Agriculture Department Warns Consumers To Discard “Hilltop Meadow Farm” Brand Contaminated ‘60 Day Aged Pepper Jack Raw Milk Cheese’
Wed, 22 Nov 2023 12:19:00 EST

  The Pennsylvania Department of Agriculture warns that consumers should discard "Hilltop Meadow Farm" brand '60 Day Aged Pepper Jack Raw Milk Cheese' with sell by dates of 9/21/2023 or earlier. Testing of this cheese confirmed the presence of Listeria monocytogenes bacteria. The Pepper Jack Raw Milk

Sofia Produce, LLC DBA Trufresh Expands Recall to Include all “Malichita” Brand and “Rudy” Brand Fresh Cantaloupe Because of Possible Health Risk Due to Salmonella
Wed, 22 Nov 2023 00:00:00 EST

  SOFIA PRODUCE, LLC, of Nogales, Arizona which does business under the name “Trufresh” (“Trufresh”) has expanded its recall of all sizes of fresh cantaloupes packaged in cardboard containers labeled with the “Malichita” label, and also labeled with the “Rudy” label to include all cantaloupes sold bet

What's New: Drugs RSS Feed

Product Quality Research Institute (PQRI) Workshop: MIDD Approaches in Pediatric Formulation Development - 02/28/2024
Fri, 08 Dec 2023 13:32:48 EST

  The objective of this workshop is to bring together industry, regulators, and academia to develop strategies to overcome current challenges with pediatric formulation development.

What's New Related to Drugs
Fri, 08 Dec 2023 11:28:06 EST

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Biosimilar Product Information
Fri, 08 Dec 2023 10:34:13 EST

  This page includes a chart of the approved biosimilar and interchangeable products. The approval of biosimilar products can improve access to care for patients by increasing the number of medication options and potentially lower costs.

Generic Drug Facilities, Sites and Organization Lists
Fri, 08 Dec 2023 10:04:37 EST

  Generic Drug Facilities, Sites and Organization Lists

Study Data Standards Resources
Fri, 08 Dec 2023 09:59:30 EST

  Study Data Standards Resources

Biosimilars | Science and Research
Fri, 08 Dec 2023 07:49:44 EST

  Learn about FDA’s latest in biosimilar science and research.

Drug Trials Snapshots
Fri, 08 Dec 2023 07:46:04 EST

  Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent. Drug Trials Snapshots provide consumers with information about who participated in clinical trials that supported the FDA approv

Novel Drug Approvals for 2022
Thu, 07 Dec 2023 16:58:13 EST

  Innovative drugs often mean new treatment options for patients and advances in health care for the American public.

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act
Thu, 07 Dec 2023 15:25:28 EST

  Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act

Written Requests Issued
Thu, 07 Dec 2023 15:17:27 EST

  Updated list of approved active moieties to which FDA has issued a Written Request for pediatric studies

CDERLearn Training and Education
Thu, 07 Dec 2023 14:03:45 EST

  Continuing Education and Training opportunities for healthcare professionals, academia, students and consumers.

Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs
Thu, 07 Dec 2023 14:02:25 EST

  Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs Guidance for Industry

Personal Importation
Thu, 07 Dec 2023 14:01:24 EST

  Personal Importation

FDA Adverse Event Reporting System (FAERS) Public Dashboard
Thu, 07 Dec 2023 13:54:23 EST

  Four FAERS summary statistics reports updated with data through December 31, 2013.

User Fee Lists
Thu, 07 Dec 2023 13:10:52 EST

  Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

Antimicrobial Resistance Information from FDA
Thu, 07 Dec 2023 12:20:11 EST

  Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

Recently Issued Guidance Documents
Thu, 07 Dec 2023 11:36:58 EST

  This page lists Recently Issued CBER and Cross-Center Guidance Documents.

FDA Drug Safety Podcasts
Thu, 07 Dec 2023 11:27:43 EST

  FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER)

FDA Roundup: December 5, 2023
Thu, 07 Dec 2023 09:41:30 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act - Revision 2
Thu, 07 Dec 2023 09:34:36 EST

  Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Whats New Vaccines Blood Biologics RSS Feed

FDA Roundup: December 5, 2023
Tue, 05 Dec 2023 16:59:37 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Drugs@FDA Data Files
Tue, 05 Dec 2023 14:43:19 EST

  Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

What’s New for Biologics
Tue, 05 Dec 2023 13:36:49 EST

  Latest news from the Center for Biologics Evaluation and Research

Biologics PREA Reviews and Labeling Changes
Tue, 05 Dec 2023 12:51:10 EST

  PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under

COVID-19: Developing Drugs and Biological Products for Treatment or Prevention
Tue, 05 Dec 2023 11:18:36 EST

  COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

Jobs at the Center for Biologics Evaluation and Research (CBER)
Tue, 05 Dec 2023 08:47:38 EST

  CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

The Importance of Clinical Trial Transparency and FDA Oversight
Mon, 04 Dec 2023 14:34:30 EST

  The U.S. Food and Drug Administration monitors compliance with the ClinicalTrials.gov registration and results information submission requirements as a critical part of our mission to protect public health.

Approved Cellular and Gene Therapy Products
Mon, 04 Dec 2023 13:39:05 EST

  Listing of licensed and approved products from the Office of Tissues and Advanced Therapies (OTAT).

Wilate
Mon, 04 Dec 2023 13:20:56 EST

  Product approval information is indicated for adults and adolescents with hemophilia A for routine prophylaxis to reduce the frequency of bleeding episodes and for on-demand treatment and control of bleeding episodes.

FDA Roundup: December 1, 2023
Fri, 01 Dec 2023 16:46:57 EST

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

ODACTRA
Fri, 01 Dec 2023 16:05:51 EST

  Product approval information for use in adults 18 through 65 years of age as immunotherapy for house dust mite- (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust m

Vaccines Licensed for Use in the United States
Fri, 01 Dec 2023 15:56:17 EST

  The product name and trade name of vaccines licensed for use in the United States.

Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement - 10/26/2021
Thu, 30 Nov 2023 13:50:20 EST

  This is the CBER Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement.

Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020
Thu, 30 Nov 2023 10:22:18 EST

  This is the CBER Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement.

Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement - 12/17/2020
Thu, 30 Nov 2023 10:21:23 EST

  This is the CBER Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement.

Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement - 04/15/2021
Thu, 30 Nov 2023 10:18:22 EST

  This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement.

Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3, 2021 Meeting Announcement - 09/02/2021
Thu, 30 Nov 2023 10:17:18 EST

  This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee September 2-3, 2021 Meeting Announcement.

Fluzone Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone, Intradermal Quadrivalent, Fluzone Quadrivalent Southern Hemisphere, Fluzone High-Dose Quadrivalent Southern Hemisphere
Thu, 30 Nov 2023 10:08:06 EST

  For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

Blood Products Advisory Committee November 4, 2021 Meeting Announcement - 11/04/2021
Thu, 30 Nov 2023 09:57:15 EST

  This is the CBER Blood Products Advisory Committee November 4, 2021 Meeting Announcement.

2021 Meeting Materials, Blood Products Advisory Committee
Thu, 30 Nov 2023 09:51:53 EST

  This is the main page for the CBER 2021 Meeting Materials, Blood Products Advisory Committee.





See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.






Products



 
 

Services




Contact Us


About PCS


Corporate Headquarters


Practical Compliance Solutions
One Orient Way
Suite F156
Rutherford, NJ 07070
  201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2023 - Copyright Practical Compliance Solutions - All rights reserved